Previous studies suggested that loss of tetrahydrobiopterin (BH 4) may play an important role in the pathogenesis of vascular endothelial dysfunction induced by diabetes and hypertension. In contrast, controversial results have been reported regarding BH 4 metabolism in experimental models of atherosclerosis. Therefore, the present study was designed to characterize the expression and activity of GTP-cyclohydrolase I, a rate-limiting enzyme in biosynthesis of BH 4, during atherogenesis. BH 4 levels were significantly increased in atherosclerotic aortas of apolipoprotein E (apoE)-deficient mice as compared with wild-type mice after 5 mo of Western diet treatment. This increase was further significantly enhanced in apoE-deficient mice fed for 9 and 14 mo. Removal of the endothelium almost eliminated BH 4 in wild-type mice but not in apoE-deficient mice, suggesting that a major component of increased BH 4 synthesis is localized in the vascular media of apoE-deficient mice. Oxidative products of BH 4 were low and did not differ between wild-type and apoE-deficient mice over the course of this study. Increased protein expression and enzymatic activity of GTP-cyclohydrolase I were detected in aortas of apoE-deficient mice (P < 0.05), providing molecular mechanisms responsible for elevation of vascular BH 4. In contrast to aortas, we did not detect any change in levels of BH 4 and in GTP-cyclohydrolase I expression in the brain. Our results demonstrate selective increase of intracellular BH 4 levels via elevation of GTP-cyclohydrolase I activity in vascular tissue of apoE-deficient mice.
|Original language||English (US)|
|Journal||American Journal of Physiology - Heart and Circulatory Physiology|
|State||Published - Jun 1 2006|
- Guanosine 5′-triphosphate-cyclohydrolase I
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)